Suppr超能文献

钠缺乏大鼠在卡托普利治疗期间肝脏血管紧张素原的合成与释放

Liver angiotensinogen synthesis and release during captopril treatment in sodium-depleted rats.

作者信息

Jaramillo H N, Sambhi M P, Bouhnik J, Corvol P, Menard J

出版信息

Endocrinology. 1987 Apr;120(4):1384-90. doi: 10.1210/endo-120-4-1384.

Abstract

In vivo generation of angiotensins depends upon both plasma renin and angiotensinogen concentrations. Those factors which may influence hepatic angiotensinogen synthesis and release were examined. We have evaluated in vivo the effects of converting enzyme inhibition on several plasma renin-angiotensin system components, and, using an in vitro preparation of liver slices, we also investigated the effects of converting enzyme inhibition on the synthesis and release of hepatic angiotensinogen. Angiotensinogen concentrations were determined by two different methods. The first was an indirect enzymatic assay which measures the amount of angiotensin I liberated from plasma by an excess of renin. The second was a direct RIA that measures both angiotensinogen and its inactive residue the des-angiotensin I-angiotensinogen. The difference between the methods represents the circulating levels of des-angiotensin I-angiotensinogen. Captopril administration in sodium-depleted rats increased plasma concentrations of renin, des-angiotensin I-angiotensinogen, and angiotensin I and decreased plasma angiotensinogen concentration measured by both methods. Plasma des-angiotensin I-angiotensinogen was significantly correlated to plasma renin concentration, which suggests an increase in the consumption of angiotensinogen when the renin secretion is extremely increased. The angiotensinogen liver content and in vitro angiotensinogen release were decreased in sodium-depleted rats treated with a converting enzyme inhibitor, and these parameters were negatively correlated to in vivo plasma levels of renin, angiotensin I, and des-angiotensin I-angiotensinogen. They were positively correlated to plasma angiotensinogen concentration measured by the indirect assay. These data suggest that captopril administration during sodium depletion has two simultaneous effects: it increases angiotensinogen consumption and second, decreases angiotensinogen production and release.

摘要

血管紧张素的体内生成取决于血浆肾素和血管紧张素原的浓度。我们研究了可能影响肝脏血管紧张素原合成和释放的因素。我们在体内评估了转换酶抑制对几种血浆肾素 - 血管紧张素系统成分的影响,并且使用肝切片的体外制备方法,我们还研究了转换酶抑制对肝脏血管紧张素原合成和释放的影响。血管紧张素原浓度通过两种不同方法测定。第一种是间接酶法,测量过量肾素从血浆中释放的血管紧张素I的量。第二种是直接放射免疫分析法,测量血管紧张素原及其无活性残基去血管紧张素I - 血管紧张素原。这两种方法之间的差异代表去血管紧张素I - 血管紧张素原的循环水平。给钠缺乏大鼠服用卡托普利会增加血浆肾素、去血管紧张素I - 血管紧张素原和血管紧张素I的浓度,并降低两种方法测得的血浆血管紧张素原浓度。血浆去血管紧张素I - 血管紧张素原与血浆肾素浓度显著相关,这表明当肾素分泌极度增加时血管紧张素原的消耗增加。用转换酶抑制剂治疗的钠缺乏大鼠肝脏血管紧张素原含量和体外血管紧张素原释放减少,并且这些参数与体内血浆肾素、血管紧张素I和去血管紧张素I - 血管紧张素原水平呈负相关。它们与间接测定法测得的血浆血管紧张素原浓度呈正相关。这些数据表明,钠缺乏期间服用卡托普利有两个同时发生的作用:它增加血管紧张素原的消耗,其次,减少血管紧张素原的产生和释放。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验